Breast-conserving surgery in BRCA1/2 mutation carriers: Are we approaching an answer?

Annals of Surgical Oncology

Volumn 16, Issue 12, 2009, Pages 3380-3387

  Garcia Etienne, Carlos A ^a   Barile, Monica ^a   Gentilini, Oreste D ^a   Botteri, Edoardo ^a   Rotmensz, Nicole ^a   Sagona, Andrea ^a   Farante, Gabriel ^a   Galimberti, Viviana ^a   Luini, Alberto ^a   Veronesi, Paolo ^a   Bonanni, Bernardo ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CANCER SIZE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; POSTOPERATIVE COMPLICATION; RECURRENCE RISK; TUMOR SUPPRESSOR GENE;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 71549153155     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0638-7     Document Type: Article

References (35)

1. U Veronesi L Mariani M Greco, et al. 2002 Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer N Engl J Med. 347 1227 1232 10.1056/NEJMoa020989 12393819 (Pubitemid 35176241)
2. B Fisher S Anderson J Bryant, et al. 2002 Twenty year follow-up of a randomized study comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med. 347 1233 1241 10.1056/NEJMoa022152 12393820 (Pubitemid 35176242)
3. BC Turner E Harrold E Matloff, et al. 1999 BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations J Clin Oncol. 17 3017 3024 1:STN:280:DyaK1MvjvVWltw%3D%3D 10506595
4. BG Haffty E Harrold AJ Khan, et al. 2002 Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status Lancet. 359 1471 1477 10.1016/S0140-6736(02)08434-9 11988246 (Pubitemid 34457765)
5. C Seynaeve LC Verhoog LM van de Bosch, et al. 2004 Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy Eur J Cancer. 40 1150 1158 10.1016/j.ejca.2004.01.017 1:STN:280:DC%2BD2c3ht1yrsQ%3D%3D 15110878 (Pubitemid 38526333)
6. LJ Pierce M Strawderman S Narod, et al. 2000 Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations J Clin Oncol. 18 3360 3369 1:STN:280:DC%2BD3M%2FgvFWmtQ%3D%3D 11013276
7. M Robson D Levin M Federici, et al. 1999 Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations J Natl Cancer Inst. 91 2112 2117 10.1093/jnci/91.24.2112 1:STN:280: DC%2BD3c%2FntFSntg%3D%3D 10601383
8. M Robson T Svahn B McCormick, et al. 2005 Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2 Cancer. 103 44 51 10.1002/cncr.20728 15558796 (Pubitemid 39665455)
9. YM Kirova D Stoppa-Lyonnet A Savignoni, et al. 2005 Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy Eur J Cancer. 41 2304 2311 10.1016/j.ejca.2005.02.037 16140006 (Pubitemid 41415607)
10. LJ Pierce AM Levin TR Rebbeck, et al. 2006 Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer J Clin Oncol. 24 2437 2443 10.1200/JCO.2005.02.7888 16636335 (Pubitemid 46630619)
11. Marubini E, Valsecchi MG. Analysing survival data from clinical trials and observational studies. Chichester: Wiley; 1995. p. 331.
12. RJ Gray 1988 A class of k-sample tests for comparing the cumulative incidence of a competing risk Ann Stat. 16 1141 1154 10.1214/aos/1176350951
13. J Jacquemier F Eisinger D Birnbaum H Sobol 1995 Histoprognostic grade in BRCA1-associated breast cancer Lancet. 345 1503 10.1016/S0140-6736(95)91060-3 1:STN:280:DyaK2M3oslOiuw%3D%3D 7769911
14. F Eisinger D Stoppa-Lyonnet M Longy F Kerangueven T Noguchi C Bailly, et al. 1996 Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer Cancer Res. 56 471 474 1:CAS:528:DyaK28XnslKqug%3D%3D 8564955
15. Breast Cancer Linkage Consortium 1997 Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases Lancet. 349 1505 1510 10.1016/S0140-6736(96)10109-4 (Pubitemid 27216361)
16. OT Johannsson I Idvall C Anderson A Borg RB Barkardottir V Egilsson, et al. 1997 Tumour biological features of BRCA1-induced breast and ovarian cancer Eur J Cancer. 33 362 371 10.1016/S0959-8049(97)89007-7 1:STN:280: DyaK2szgtVCqtQ%3D%3D 9155518 (Pubitemid 27168060)
17. M Robson P Rajan PP Rosen T Gilewski Y Hirschaut P Pressman, et al. 1998 BRCA-associated breast cancer: absence of a characteristic immunophenotype Cancer Res. 58 1839 1842 1:CAS:528:DyaK1cXislentr4%3D 9581822
18. LC Verhoog CT Brekelmans C Seynaeve LM van den Bosch G Dahmen AN van Geel, et al. 1998 Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1 Lancet. 351 316 321 10.1016/S0140-6736(97) 07065-7 1:STN:280:DyaK1czhsVOiuw%3D%3D 9652611 (Pubitemid 28052696)
19. N Loman O Johannsson PO Bendahl A Borg M Ferno H Olsson 1998 Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes Cancer. 83 310 319 10.1002/(SICI)1097-0142(19980715)83:2<310::AID-CNCR15>3.0.CO;2-W 1:CAS:528:DyaK1cXkvVensrs%3D 9669814 (Pubitemid 28317811)
20. P Osin BA Gusterson E Philp J Waller J Bartek J Peto, et al. 1998 Predicted anti-oestrogen resistance in BRCA-associated familial breast cancers Eur J Cancer. 34 1683 1686 10.1016/S0959-8049(98)00248-2 1:CAS:528: DyaK1cXntlShtbg%3D 9893652 (Pubitemid 28474219)
21. M Clarke R Collins S Darby, et al. 2005 Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials Lancet. 366 2087 2106 1:STN:280:DC%2BD2MnnsVSitA%3D%3D 16360786
22. K Metcalfe HT Lynch P Ghadirian, et al. 2004 Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers J Clin Oncol. 22 2328 2335 10.1200/JCO.2004.04.033 1:CAS:528:DC%2BD2cXpsVWltbs%3D 15197194 (Pubitemid 41115389)
23. T Rebbeck A Levin A Eisen, et al. 1999 Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers J Natl Cancer Inst. 91 1475 1479 10.1093/jnci/91.17.1475 1:STN:280:DyaK1MvgtVyisw%3D%3D 10469748
24. T Rebbeck H Lynch S Neuhausen, et al. 2002 Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med. 346 1616 1622 10.1056/NEJMoa012158 12023993 (Pubitemid 34755669)
25. J Gronwald N Tung WD Foulkes, et al. 2006 Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update Int J Cancer. 118 2281 2284 10.1002/ijc.21536 1:CAS:528:DC%2BD28XjsVCgt7Y%3D 16331614
26. TC van Sprundel MK Schmidt MA Rookus, et al. 2005 Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers Br J Cancer 93 287 292 10.1038/sj.bjc.6602703 16052221 (Pubitemid 43080030)
27. LC Hartmann TA Sellers DJ Schaid, et al. 2001 Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers J Natl Cancer Inst. 93 1633 1637 10.1093/jnci/93.22.1733 1:CAS:528:DC%2BD3MXptVegt7g%3D 11698567
28. H Meijers-Heijboer B Van Geel WLJ Van Putten, et al. 2001 Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med. 345 159 164 10.1056/NEJM200107193450301 1:CAS:528: DC%2BD3MXlslSlt7g%3D 11463009 (Pubitemid 32662123)
29. T Rebbeck T Friebel H Lynch, et al. 2004 Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group J Clin Oncol. 22 1055 1062 10.1200/JCO.2004.04.188 14981104 (Pubitemid 41095038)
30. AE Giuliano S Boolbol A Degnim 2007 Society of surgical oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007 Ann Surg Oncol 14 2425 2427 10.1245/s10434-007-9447-z 17597344 (Pubitemid 47389578)
31. KA Metcalfe J Lubinski P Ghadirian, et al. 2008 Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: The Hereditary Breast Cancer Clinical Study Group J Clin Oncol. 26 1093 1097 10.1200/JCO.2007.12.6078 18195327
32. SE Singletary 2002 Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy Am J Surg. 184 383 393 10.1016/S0002-9610(02)01012-7 12433599 (Pubitemid 35335942)
33. L Mariani B Salvadori E Marubini, et al. 1998 Ten-year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer Eur J Cancer. 34 1156 1162 10.1016/S0959-8049(98)00137-3 1:STN:280:DyaK1M%2Fms1egtw%3D%3D 9849473 (Pubitemid 28342103)
34. S Hellman 1999 The key and the lamppost J Clin Oncol. 17 3007 3008 1:STN:280:DyaK1MvjvVWlsQ%3D%3D 10506593
35. MC King S Wieand K Hale, et al. 2001 Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial JAMA 286 18 2251 2256 10.1001/jama.286.18.2251 1:CAS:528: DC%2BD3MXosFCktr8%3D 11710890